Articles

Analysis of rare driving events in pediatric acute myeloid leukemia

Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam
US Biologic, Inc, Memphis, Tennessee
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee
AML-BFM Study Group, Pediatric Hematology and Oncology, Essen
Women and Child Health Department, Hematology-Oncology Clinic and Lab, University of Padova, Padova
Italian Association of Pediatric Hematology and Oncology, University of Pavia, Pavia
Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus
Nordic Society for Pediatric Hematology and Oncology, Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg
Center of molecular biology and gene therapy, Department of Internal Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens
Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens
Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht
Department of Cell Biology, Erasmus MC, Rotterdam
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht
Haematologica Early view Jul 28, 2022 https://doi.org/10.3324/haematol.2021.280250